It is made from human blood plasma and is, therefore, known as a biologic drug product.
Administering IVIG products to these individuals aims to normalize their immune systems and relieve these symptoms.
Getty Images /Willowpix
Immunoglobulins and IVIG
Immunoglobulins are also known asantibodies.
Getty Images /Willowpix
They are proteins that are produced by your blood when your body detectsantigens.
Immunoglobulins attach to these foreign substances, which helps your other immune cells destroy them.
IVIG therapy is made by isolating immunoglobulin proteins from donated blood and plasma of other people.
Most manufacturers of IVIG therapy use tens of thousands ofhealthy donorsto continue producing pure and safe IVIG products.
These conditions are characterized by low immunoglobulin levels and may affect both adults and children.
IVIG is typically given in supervised outpatient parameters, such as health clinics or infusion suites.
It may also be given in the hospital.
Once youve had several successful infusions without any reactions, your infusion may take just one to two hours.
This is why your infusions are supervised by a medical practitioner.
Home health nurses helping you with your infusion at home will typically follow a protocol for infusion reactions.
Is IVIG Therapy Effective?
For most of these conditions, it is considered standard therapy.
The results showed:
Another study looked at how effective IVIG therapy was for CIDP.
Participants received an IVIG or placebo infusion every three weeks.
Disability was measured at 24 weeks.
UpToDate.Patient education: intravenous immune globulin (IVIG) (beyond the basics).
Hooper JA.Intravenous immunoglobulins: evolution of commercial IVIG preparations.Immunol Allergy Clin North Am.
2017;139(3S):S1-S46.
doi:10.1016/j.jaci.2016.09.023
Centers for Disease Control and Prevention.Primary immunodeficiency (PI).
Jusufovic E, Sinanovic O, et al.Multifocal motor neuropathy: case reports.Acta Clin Croat.
2018 Sep;57(3):581-587.
Guo Y, Tian X, et al.Adverse effects of immunoglobulin therapy.Front Immunol.
2020;408:116497. doi:10.1016/j.jns.2019.116497
Zahavi D, Weiner L.Monoclonal antibodies in cancer therapy.Antibodies (Basel).
2019 Aug 8;7:295.
2019;12(10):100068. doi:10.1016/j.waojou.2019.100068
